For patients managing chronic inflammation as part of a broader longevity strategy, BPC-157 may fit alongside compounds like Low Dose Naltrexone (LDN), which modulates immune activity through a separate mechanism involving endorphin and toll-like receptor signaling, and metabolic interventions that address the upstream drivers of inflammaging
This is why many users report that after 3 to 5 months: Sleep quality declines Fat loss slows or stops Energy levels drop Results plateau In some cases, biomarkers such as IGF-1 can even fall below baseline after prolonged overstimulation
The difficulties associated with speech and swallowing could be addressed by speech therapy
The results suggest GLP-1s have benefits beyond weight loss
W., et al., Contribution of Reactive Oxygen Species to Cerebral Amyloid Angiopathy, Vasomotor Dysfunction, and Microhemorrhage in Aged Tg2576 Mice, Proceedings of the National Academy of Sciences of the United States of America 112 (2015): E881E890, 10.1073/pnas.1414930112
Nausea was more common with liraglutide (27%) on 18 mg
